Declining measles antibodies in the era of elimination: Australia's experience

被引:36
作者
Gidding, Heather F. [1 ,2 ]
Quinn, Helen E. [2 ]
Hueston, Linda [3 ]
Dwyer, Dominic E. [3 ]
McIntyre, Peter B. [2 ]
机构
[1] Univ New South Wales, UNSW Med, Sch Publ Hlth & Community Med, Sydney, NSW, Australia
[2] Natl Ctr Immunisat Res & Surveillance, Westmead, NSW, Australia
[3] Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, New South Wales Hlth Pathol, Inst Clin Pathol & Med Res, Westmead, NSW, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
Measles; Seroprevalence; Vaccination; Immunity; RUBELLA ANTIBODIES; CONTROL CAMPAIGN; MMR VACCINE; B-CELL; IMMUNITY; MUMPS; CHILDREN; SEROPREVALENCE; PERSISTENCE; POPULATION;
D O I
10.1016/j.vaccine.2017.12.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Australia is one of only a few countries with a long-standing and consistent serosurveillance program. We conducted a national serosurvey in 2012-2013 to estimate population seroprevalence of measles-specific IgG and the effective reproduction number, R, and compare the results with the three previous serosurveys (1996-1999, 2002 and 2007) to examine trends following a decade of sustained measles control. Methods: 2729 residual sera from 1 to 49 year olds were tested using the Enzygnost anti-measles IgG enzyme immunoassay (EIA). All sera in the equivocal range by EIA on re-testing and a random sample of low positive and negative sera were later tested by a microneutralisation assay. R was calculated from weighted estimates of the proportion seronegative by age using a previously developed contact matrix. Results: In the 2012-13 serosurvey, anti-measles IgG seropositivity for 1-49 year olds was 80.8% (95% CI: 79.4-82.3%) and 8.9% (95% CI: 7.8-10.0%) had equivocal antibody levels. The increasing proportion of seronegative and equivocal individuals in age groups 10-39 years continued a trend seen in previous serosurveys. There was also an increase in equivocal results among 2-4 and 5-9 year old children, >90% of whom were recently vaccinated. R increased from 0.57 in 1999 to above the epidemic threshold of 1 in 2012-13 (R = 1.7). All 20 EIA negative sera, 238/241 (98.8%) equivocal sera, and 89/92 (96.7%) low positive sera had a titre <10 (negative) in the measles microneutralisation assay. Conclusions: A number of countries with sustained measles control have now demonstrated that measles-specific IgG antibodies decline with time since vaccination. As there is good epidemiologic evidence of population-level protection, the implications of declining measles-specific IgG antibody levels for maintaining measles elimination are unclear. Novel studies to determine correlates of protection against measles transmission and disease in the post-elimination era are needed to help answer this question. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:507 / 513
页数:7
相关论文
共 38 条
  • [1] Prevalence of antibodies against measles, mumps and rubella in the childhood population in Singapore, 2008-2010
    Ang, L. W.
    Lai, F. Y.
    Tey, S. H.
    Cutter, J.
    James, L.
    Goh, K. T.
    [J]. EPIDEMIOLOGY AND INFECTION, 2013, 141 (08) : 1721 - 1730
  • [2] [Anonymous], 3 ANN M REG VER COMM
  • [3] [Anonymous], AUSTR IMM HDB
  • [4] Neutralizing B cell response in measles
    Bouche, FB
    Ertl, OT
    Muller, CP
    [J]. VIRAL IMMUNOLOGY, 2002, 15 (03) : 451 - 471
  • [5] Waning population immunity to measles in Taiwan
    Chen, Chih-Jung
    Lee, Ping-Ing
    Hsieh, Yu-Chia
    Chen, Po-Yen
    Ho, Yu-Huai
    Chang, Chee-Jen
    Liu, Ding-Ping
    Chang, Feng-Yee
    Chiu, Cheng-Hsun
    Huang, Yhu-Chering
    Lee, Chin-Yun
    Lin, Tzou-Yien
    [J]. VACCINE, 2012, 30 (47) : 6721 - 6727
  • [6] Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: A 20-year follow-up
    Davidkin, Irja
    Jokinen, Sari
    Broman, Mia
    Leinikki, Pauli
    Peltola, Heikki
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (07) : 950 - 956
  • [7] De Serres G, 2000, AM J EPIDEMIOL, V151, P1039, DOI 10.1093/oxfordjournals.aje.a010145
  • [8] DIEKMANN O, 1990, J MATH BIOL, V28, P365
  • [9] Modelling the incidence of measles in Canada: an assessment of the options for vaccination policy
    Gay, NJ
    Pelletier, L
    Duclos, P
    [J]. VACCINE, 1998, 16 (08) : 794 - 801
  • [10] Verification of measles elimination in Australia: Application of World Health Organization regional guidelines
    Gidding H.F.
    Martin N.V.
    Stambos V.
    Tran T.
    Dey A.
    Dowse G.K.
    Kelly H.A.
    Durrheim D.N.
    Lambert S.B.
    [J]. Journal of Epidemiology and Global Health, 2016, 6 (3) : 197 - 209